Alclometasone dipropionate topical
- Drugs List
- Therapeutic Indications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
Topical preparations of alclometasone dipropionate
Skin conditions responsive to topical corticosteroids
For the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
1 application sparingly to the affected area two to three times a day.
See Dosage; Adult.
Precautions and Warnings
Contains cetostearyl alcohol: may cause irritation
Contains propylene glycol: may cause irritation
Occlusive dressings can increase the likelihood of systemic absorption
Adrenal suppression may occur even without occlusion
Prolonged/excessive use may lead to adrenal suppression
Discontinue if irritation or sensitisation occur
Avoid long term continuous therapy
Advise patient residue on clothing/bedding may cause fire hazard
Fire hazard: Keep away from naked flames and potential sources of ignition
Systemic absorption of topical corticosteroids may be increased if extensive body surface areas are treated or if the occlusive technique is used. Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children.
Paediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients due to a greater absorption due to a large skin surface area to body weight ratio.
HPA suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and an absence of response to ACTH stimulation. Manifestations of intracranial hypertension include a bulging fontanelle, headaches and bilateral papilloedema.
Pregnancy and Lactation
Use alclometasone dipropionate with caution during pregnancy.
The manufacturer advises caution if alclometasone dipropionate is used during pregnancy. At the time of writing, safety of topical corticosteroid use during pregnancy has not been established and should only be used if the potential benefit justifies the potential risk to the foetus. It is recommended to avoid using large amounts and for long periods of time if possible.
Use alclometasone dipropionate with caution during breastfeeding.
The manufacturer advises caution if alclometasone dipropionate is used during breastfeeding. At the time of writing it is unknown whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Effects on exposed infants are unknown.
Allergic contact dermatitis
Erythema at application site
Growth retardation (children)
Itching at application site
Maceration of skin
Superficial vascular dilation
Suppression of the hypothalamic-pituitary-adrenal axis
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Last Full Review Date: October 2020
Summary of Product Characteristics: Alclometasone Dipropionate 0.05% w/w cream. Aspire Pharma Ltd. Revised December 2019.
NICE Evidence Services Available at: www.nice.org.uk Last accessed: 13 October 2020
Already a member? Log in
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.